Article
An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder.
Journal of cellular and molecular medicine - 1 Mar 2021
Cameli Cinzia, Viggiano Marta, Rochat Magali J, Maresca Alessandra, Caporali Leonardo, Fiorini Claudio, Palombo Flavia, Magini Pamela, Duardo Renée C, Ceroni Fabiola, Scaduto Maria C, Posar Annio, Seri Marco, Carelli Valerio, Visconti Paola, Bacchelli Elena, Maestrini Elena
Abstract excerpt
Autism spectrum disorder (ASD) is characterized by a complex polygenic background, but with the unique feature of a subset of cases (~15%-30%) presenting a rare large-effect variant. However, clinical interpretation in these cases is often complicated by incomplete penetrance, variable expressivity and different neurodevelopmental trajectories. NRXN1 intragenic deletions represent the prototype of such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
